These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 19256335)

  • 41. A high throughput dimer screening assay for monoclonal antibodies using chemical cross-linking and microchip electrophoresis.
    Chen X; Flynn GC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(27):3012-8. PubMed ID: 19646934
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of human metabolites of (-)-N-{2-[(R)-3-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-2-carbonyl)piperidino]ethyl}-4-fluorobenzamide (YM758), a novel If channel inhibitor, and investigation of the transporter-mediated renal and hepatic excretion of these metabolites.
    Umehara K; Shirai N; Iwatsubo T; Noguchi K; Usui T; Kamimura H
    Drug Metab Dispos; 2009 Aug; 37(8):1646-57. PubMed ID: 19439489
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development of a High-Throughput Calcium Mobilization Assay for CCR6 Receptor Coupled to Hydrolase Activity Readout.
    Gómez-Melero S; García-Maceira FI; García-Maceira T; Luna-Guerrero V; Montero-Peñalvo G; Caballero-Villarraso J; Túnez I; Paz-Rojas E
    Biomedicines; 2022 Feb; 10(2):. PubMed ID: 35203631
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neurobiology with caged calcium.
    Ellis-Davies GC
    Chem Rev; 2008 May; 108(5):1603-13. PubMed ID: 18447376
    [No Abstract]   [Full Text] [Related]  

  • 45. High-throughput screening of catalysts by combining reaction and analysis.
    Trapp O; Weber SK; Bauch S; Hofstadt W
    Angew Chem Int Ed Engl; 2007; 46(38):7307-10. PubMed ID: 17668428
    [No Abstract]   [Full Text] [Related]  

  • 46. High-throughput multilevel performance screening of advanced materials.
    Potyrailo RA; Pickett JE
    Angew Chem Int Ed Engl; 2002 Nov; 41(22):4230-3. PubMed ID: 12434347
    [No Abstract]   [Full Text] [Related]  

  • 47. Recent patents in high-throughput screening.
    Nat Biotechnol; 2000 Jul; 18(7):797. PubMed ID: 10888854
    [No Abstract]   [Full Text] [Related]  

  • 48. High-throughput screening of small interfering ribonucleic acid identifies important modulators in islet dysfunction and apoptosis.
    Nemoto M; Sasaki T
    J Diabetes Investig; 2015 Jul; 6(4):390-2. PubMed ID: 26221516
    [No Abstract]   [Full Text] [Related]  

  • 49. A model was sensitive but not specific for screening for tuberculosis in contact patients.
    Menzies D
    ACP J Club; 2008; 149(4):15. PubMed ID: 18937393
    [No Abstract]   [Full Text] [Related]  

  • 50. Correction to: High-Throughput Screening for Insulin Secretion Modulators.
    Kalwat MA
    Methods Mol Biol; 2021; 2233():C1. PubMed ID: 33502748
    [No Abstract]   [Full Text] [Related]  

  • 51. Maximal limits on the information throughput of spatial light modulators.
    Caulfield HJ; Schamschula MP; Zhang L
    Opt Lett; 1995 Sep; 20(17):1803. PubMed ID: 19862163
    [No Abstract]   [Full Text] [Related]  

  • 52. TRPV3: Structure, Diseases and Modulators.
    Su W; Qiao X; Wang W; He S; Liang K; Hong X
    Molecules; 2023 Jan; 28(2):. PubMed ID: 36677834
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Establishment of a cell based high throughput screening model for transient receptor potential V3 modulators].
    Wang S; Li J; Peng Z; Cao J
    Sheng Wu Gong Cheng Xue Bao; 2008 Nov; 24(11):1895-901. PubMed ID: 19256335
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Use of FLIPR membrane potential dyes for validation of high-throughput screening with the FLIPR and microARCS technologies: identification of ion channel modulators acting on the GABA(A) receptor.
    Joesch C; Guevarra E; Parel SP; Bergner A; Zbinden P; Konrad D; Albrecht H
    J Biomol Screen; 2008 Mar; 13(3):218-28. PubMed ID: 18270364
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacological profiling of the TRPV3 channel in recombinant and native assays.
    Grubisha O; Mogg AJ; Sorge JL; Ball LJ; Sanger H; Ruble CL; Folly EA; Ursu D; Broad LM
    Br J Pharmacol; 2014 May; 171(10):2631-44. PubMed ID: 23848361
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Utility of large-scale transiently transfected cells for cell-based high-throughput screens to identify transient receptor potential channel A1 (TRPA1) antagonists.
    Chen J; Lake MR; Sabet RS; Niforatos W; Pratt SD; Cassar SC; Xu J; Gopalakrishnan S; Pereda-Lopez A; Gopalakrishnan M; Holzman TF; Moreland RB; Walter KA; Faltynek CR; Warrior U; Scott VE
    J Biomol Screen; 2007 Feb; 12(1):61-9. PubMed ID: 17099245
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.